Octagon Therapeutics

0 followers


Octagon is developing new medicines for autoimmune disease based on selective immunomodulation.

Industries

Headquarters

Stage

Employees

Links

Org chart

Isaac Stoner
President & CEO

Isaac Stoner

Collapse
Fred Ausubel
Founding CSO
Brent Cezairliyan
VP of Biology
Nat Sherden
VP of Chemistry
Luis Castillo Menendez
Director of Translation & Development